1Green JA, Kirwan JM. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix, a systematic review and meta analysis [J ]. Lancet, 2001, 358(9284). 781.
2Mieheleti E. Laface B. Bianehi E, et al. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squarnous carcinoma of the cervix uteri ⅡB- ⅢB (UICC). A phase Ⅰ-Ⅱ and pharmacokinetic study[J]. Am J Clin Oncol. 1997, 20: 613.
5Johan A, Johan W, Anders J, et al. Antitumer effect radioactive eisplatin on mude mice[J]. Int J Radial Oncol Biol Phy, 2001, 49(3): 827.
二级参考文献6
1Green JA,Kirwan JM. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis[J]. Lancet,2001,358(9284):781.
2Walboomers JM,Jacobs MV,Manos MM,et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol,1999,189(1):12-19.
4Green JA,Kirwan JM. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta analysis[J].Lancet,2001,358(9284):781.
5Alfonso DG,Cetina L,Sanchez B,et al.A phase Ⅰstudy of carboplatin concurrent with radiation in FIGO stage Ⅲb cervix uteri carcinoma[J].Int J Ratiat Oncol Biol Phys,2003,56(5):1361-1365.
6Pignata S,Frezza P,Tramontana S,et al. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri[J]. Ann Oncol,2000,11(4):455-459.
